Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
American Journal of Translational Research
|
May 10, 2016
Epirubicin pretreatment enhances NK cell-mediated cytotoxicity against breast cancer cells in vitro
Hui Feng, Ying Dong, Jing Wu, et al.
Frontiers in Molecular Biosciences
|
July 23, 2021
Novel Nanoliposomes Alleviate Contrast-Induced Nephropathy by Mediating Apoptosis Response in New Zealand Rabbits
Peng Zhang, Xue Zhang, Jing Zhang, et al.
Carcinogenesis
|
January 1, 2019
Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival
Xiaomeng Wang, Hongliang Liu, Yinghui Xu, et al.
Journal of Inflammation Research
|
April 3, 2023
Association of Neutrophil-to-Lymphocyte Ratio with Nutrition in Patients with Various Types of Malignant Tumors: A Multicenter Cross-Sectional Study
Lihua Kang, Xiangliang Liu, Wei Ji, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2023
Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study)
Jiayu Wang, Li Cai, Yanqiu Song, et al.
Acta Biomaterialia
|
July 25, 2025
Controlled Delivery of C-C Motif Chemokine Ligand 25 by a Hydrogel for Tumor Microenvironment Remodeling in Triple Negative Breast Cancer
Meng Guan, Junfeng Ding, Ge Zhu, et al.
Science Advances
|
February 18, 2020
Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9<sup>+</sup> T cells
Hongmei Chen, Xiuxiu Cong, Chenxi Wu, et al.
JAMA Oncology
|
August 26, 2021
Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators: A Phase 2 Randomized Clinical Trial
Ying Fan, Tao Sun, Zhimin Shao, et al.
Molecular Genetics & Genomic Medicine
|
April 11, 2019
Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high-risk breast cancer
Xiaozhen Wang, Haimeng Liu, Amina Maimaitiaili, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 23, 2016
[A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]
Binghe Xu, Fuguo Tian, Jingrui Yu, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
American Journal of Translational Research
|
May 10, 2016
Epirubicin pretreatment enhances NK cell-mediated cytotoxicity against breast cancer cells in vitro
Hui Feng, Ying Dong, Jing Wu, et al.
Frontiers in Molecular Biosciences
|
July 23, 2021
Novel Nanoliposomes Alleviate Contrast-Induced Nephropathy by Mediating Apoptosis Response in New Zealand Rabbits
Peng Zhang, Xue Zhang, Jing Zhang, et al.
Carcinogenesis
|
January 1, 2019
Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival
Xiaomeng Wang, Hongliang Liu, Yinghui Xu, et al.
Journal of Inflammation Research
|
April 3, 2023
Association of Neutrophil-to-Lymphocyte Ratio with Nutrition in Patients with Various Types of Malignant Tumors: A Multicenter Cross-Sectional Study
Lihua Kang, Xiangliang Liu, Wei Ji, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2023
Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study)
Jiayu Wang, Li Cai, Yanqiu Song, et al.
Acta Biomaterialia
|
July 25, 2025
Controlled Delivery of C-C Motif Chemokine Ligand 25 by a Hydrogel for Tumor Microenvironment Remodeling in Triple Negative Breast Cancer
Meng Guan, Junfeng Ding, Ge Zhu, et al.
Science Advances
|
February 18, 2020
Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9<sup>+</sup> T cells
Hongmei Chen, Xiuxiu Cong, Chenxi Wu, et al.
JAMA Oncology
|
August 26, 2021
Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators: A Phase 2 Randomized Clinical Trial
Ying Fan, Tao Sun, Zhimin Shao, et al.
Molecular Genetics & Genomic Medicine
|
April 11, 2019
Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high-risk breast cancer
Xiaozhen Wang, Haimeng Liu, Amina Maimaitiaili, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 23, 2016
[A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]
Binghe Xu, Fuguo Tian, Jingrui Yu, et al.
Page
of 7